If you have been reading about CJC-1295 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-15. Where a claim depends on a specific study, the study is described rather than over-claimed.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
Characterization of this peptide relies on a small set of routine techniques. Reversed-phase high-performance liquid chromatography separates the target from truncated or oxidized by-products and yields a purity estimate when paired with ultraviolet detection near 214 nanometers. Mass spectrometry, either electrospray coupled to liquid chromatography or matrix-assisted laser desorption, confirms that the observed mass matches the value calculated for the expected sequence. Amino acid analysis, and enzymatic digestion followed by fragment mapping, are used when the sequence itself rather than the mass requires verification.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
During the first Trump administration, US president Donald Trump said that the United States should buy Greenland. The governments of Denmark and Greenland clarified that Greenland is not for sale and cannot be sold under the Danish constitution, and the Danish government has always rejected such proposals, which Prime Minister Mette Frederiksen called "an absurd discussion". Greenland invited American investment, however, stating that "we're open for business, not for sale". In December 2024, President-elect Trump, before the onset of his second administration, reiterated his interest in the United States assuming control of Greenland, stating that "for purposes of national security and freedom throughout the world, the United States of America feels that the ownership and control of Greenland is an absolute necessity."
=== IATSE strike === Problems kept coming on July 16, when thirty to thirty-five crew members went on strike to demand better wages and benefits, under encouragement from the IATSE union, whose local representative warned that the dispute would cost The Stone Group an additional $40,000 per day. The production was sanctioned by the Directors Guild of America and Screen Actors Guild, but did not recognize other labor groups. As such, the film's technicians were signed to a flat fee. Filming was again suspended but, since Mississippi was a right-to-work state, the concerned workers were summarily fired and fifty new ones were brought in. This included cinematographer Leonetti, who was replaced by Alexander Gruszynski and complained that he stood to lose $50,000 in wages. Meanwhile, on July 17, Bosworth was officially released from his NFL contract by the Seattle Seahawks, although this was expected due to his persistent shoulder issues, and he already considered himself an actor first.
He saw that Britain's future lay in being part of the European Economic Community, and he established ties with the European Organization for Nuclear Research (CERN), the European Molecular Biology Organization (EMBO) and the European Space Research Organization (ESRO). In 1959, the Royal Society provided for only one research fellowship, the Foulerton Professorship, but in 1961, at his suggestion, the Henry Dale Research Professorship was created for a researcher in physiology and pharmacology. Government funding was provided to create three more professorships in 1964, and another two in 1967. Reflecting his attempt to move with the times, a chair was established for the social sciences, and two new lecture series were instituted, for technology and the behavioural sciences. Aware of the acute danger of overpopulation that the life-saving drugs that he had pioneered could cause, he established a population study group, and in 1967, he became the president of the Family Planning Association.
Protactinium (91Pa) has no stable isotopes. As 231Pa occurs in usable quantity, and comprises virtually all of the element, it defines the standard atomic weight. Thirty radioisotopes of protactinium have been characterized, ranging from 210Pa to 239Pa. The most stable isotopes are 231Pa with a half-life of 32,700 years, 233Pa with a half-life of 26.975 days, and 230Pa with a half-life of 17.4 days. All of the remaining radioactive isotopes have half-lives less than 1.6 days, and the majority of these have half-lives less than 1.8 seconds. This element also has five meta states, 217mPa (t1/2 1.15 milliseconds), 220m1Pa (t1/2 = 308 nanoseconds), 220m2Pa (t1/2 = 69 nanoseconds), 229mPa (t1/2 = 420 nanoseconds), and 234mPa (t1/2 = 1.16 minutes). The only naturally occurring isotopes are 231Pa, 233Pa, 234Pa, and 234mPa. The first occurs as an intermediate decay product of 235U, the second of (rare) 237Np, and the last two as intermediate decay products of 238U. 231Pa dominates solely because of its longer life. The primary decay mode for protactinium isotopes lighter than (and including) the most stable isotope 231Pa is alpha decay to isotopes of actinium, except 228Pa to 230Pa, which primarily decay by electron capture to isotopes of thorium. The primary mode for the heavier isotopes is beta minus (β−) decay to isotopes of uranium.
=== Post-invasion Iraq === Returning to Iraq following the 2003 US-led invasion, the group changed its name from brigade to organization in response to the attempted voluntary disarming of Iraqi militias by the Coalition Provisional Authority. It is however widely believed the organization was still active as a militia within the security forces and it had been accused of running a secret prison and sectarian killings during the Iraqi Civil War. Because of their opposition to Saddam Hussein, the Badr Brigade was seen as a U.S. asset in the fight against Baathist partisans. After the fall of Baghdad, Badr forces reportedly joined the newly reconstituted army, police, and the Interior Ministry in significant numbers. The Interior Ministry was controlled by SCIRI, and many Badr members became part of the Interior Ministry-run Wolf Brigade. The Iraqi Interior Minister, Bayan Jabr, was a former leader of Badr Brigade militia. In 2006 the United Nations human rights chief in Iraq, John Pace, said that hundreds of Iraqis were being tortured to death or executed by the Interior Ministry under SCIRI's control. According to a 2006 report by the Independent newspaper:
Sources: en.wikipedia.org
The 2001 Copa América, hosted by Colombia, was nearly lost to the country's security situation. CONMEBOL held three meetings on the matter: on 28 June 2001 the tournament was moved out of Colombia, on 30 June it was returned but postponed to 2002, and on 5 July the original schedule was confirmed. Canada, one of two invited guests, withdrew on 6 July and Argentina on 10 July, the day before the opening match; Costa Rica and Honduras were invited in their place. Honduras arrived with a hastily assembled squad and went on to reach the semi-finals. Colombia won Group A with maximum points, all three matches played at the Estadio Metropolitano Roberto Meléndez in Barranquilla: Venezuela were beaten 2–0 through Freddy Grisales and a Víctor Aristizábal penalty, Ecuador 1–0 through Aristizábal, and Chile 2–0 through an Aristizábal penalty and a 90th-minute goal from Iván Arriaga. Peru were beaten 3–0 in the quarter-finals at Armenia, Aristizábal scoring twice, and Honduras — who had eliminated Brazil in the previous round — were beaten 2–0 in the semi-final at the Estadio Palogrande in Manizales, Bedoya scoring inside six minutes and Aristizábal adding the second. In the final at the Estadio El Campín in Bogotá on 29 July, before 47,000 spectators, Iván Córdoba headed in the only goal in the 65th minute to beat Mexico 1–0 and win Colombia's first major trophy. Colombia won the competition without conceding a goal, keeping six clean sheets in six matches and scoring eleven, the highest total of the tournament.
Clusters can be found in all classes of chemical compounds. According to the commonly accepted definition, a cluster consists minimally of a triangular set of atoms that are directly bonded to each other. But metal–metal bonded dimetallic complexes are highly relevant to the area. Clusters occur in "pure" inorganic systems, organometallic chemistry, main group chemistry, and bioinorganic chemistry. The distinction between very large clusters and bulk solids is increasingly blurred. This interface is the chemical basis of nanoscience or nanotechnology and specifically arise from the study of quantum size effects in cadmium selenide clusters. Thus, large clusters can be described as an array of bound atoms intermediate in character between a molecule and a solid.
=== EC 1.1.99 With unknown physiological acceptors === EC 1.1.99.1: choline dehydrogenase EC 1.1.99.2: L-2-hydroxyglutarate dehydrogenase EC 1.1.99.3: gluconate 2-dehydrogenase (acceptor) EC 1.1.99.4: dehydrogluconate dehydrogenase EC 1.1.99.5: now EC 1.1.5.3, glycerol-3-phosphate dehydrogenase EC 1.1.99.6: D-2-hydroxy-acid dehydrogenase EC 1.1.99.7: lactate—malate transhydrogenase EC 1.1.99.8: Now EC 1.1.2.7, methanol dehydrogenase (cytochrome c) and EC 1.1.2.8, alcohol dehydrogenase (cytochrome c).
Her initial drawings and continual discoveries contribute to a broader understanding of protein energetics and evolution. Peter Agre, Nobel laureate and fellow Duke professor, said of the Richardsons' work: "Jane and David’s work allowed us to reveal the form of proteins, and from there it was easier to understand their function". The Richardsons' more recent work has diversified beyond classification and crystallography. In the 1980s they stretched into the fields of synthetic biochemistry and computational biology as pioneers in the de novo design of proteins, a reverse engineering approach to make and test theoretical predictions about protein folding. In the 1990s the Richardsons developed the kinemage system of molecular graphics and David Richardson wrote the Mage program to display them on small computers, for the then-new journal Protein Science. Additionally, they developed all-atom contact analysis (see image) to measure "goodness of fit" inside proteins and in interactions with surrounding molecules. The Kinemage website offers interactive exploration of various 3D protein structures through computer displays using their Mage or KiNG graphics programs. Funded by a National Institutes of Health (NIH) grant, the website is often used as a teaching tool. Textbooks and internet sites that have sourced images from Kinemages include Introduction to Protein Structure by Branden & Tooze, Fundamentals of Biochemistry by Viet, Voet & Pratt, Principles of Biochemistry by Horton et al., and the University of Mississippi's Kinemage Authorship Project.
Icotrokinra, sold under the brand name Icotyde, is a medication used for the treatment of plaque psoriasis. It is a cyclic peptide that functions as a selective interleukin 23 (IL-23) receptor antagonist. It is a synthetic peptide that binds selectively to the IL-23 receptor (IL-23R) with high affinity and competitively antagonizes the binding of IL-23. It is an immunosuppressant and interleukin inhibitor. It is being developed by Johnson & Johnson. Icotrokinra was approved for medical use in the United States in March 2026.
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
Natural GHRH is degraded quickly by dipeptidyl peptidase-4 and related enzymes, giving it a half-life measured in minutes. CJC-1295 carries substitutions that slow that breakdown, so it stays intact longer. Both act at the same pituitary receptor and produce the same class of signal.